private:indeltherapeutics
|
493915
|
Mar 23rd, 2018 12:00AM
|
Indel Therapeutics Inc.
|
96
|
0.00
|
Open
|
Biotechnology
|
Mar 23rd, 2017 10:51AM
|
Mar 23rd, 2017 10:51AM
|
Company has ceased operations.
Indel Therapeutics Inc. was a biopharmaceutical company dedicated to developing new drugs to address the global health crisis caused by antibiotic resistance. The Company had a growing pipeline of novel antibiotic drug discovery programs that focus on curing difficult-to-treat and hospital-acquired infections. These programs were based on Indel’s paradigm-changing antimicrobial drug discovery platform, a patented technology that opened a rich, new area of drug targets for the treatment of bacterial and parasitic infections and, potentially, fungal and viral infections.
If you are interested in this technology/platform please contact the University Industry Liaison Office at the University of British Columbia.
|
|
|
|
|
|
|
|
|
|
Indel Therapeutics
|
|
Health Care Equipment & Services
|
private:indeltherapeutics
|
493915
|
Feb 17th, 2018 12:00AM
|
Indel Therapeutics Inc.
|
96
|
0.00
|
Open
|
Biotechnology
|
Feb 17th, 2018 02:25PM
|
Feb 17th, 2018 02:25PM
|
Company has ceased operations.
Indel Therapeutics Inc. was a biopharmaceutical company dedicated to developing new drugs to address the global health crisis caused by antibiotic resistance. The Company had a growing pipeline of novel antibiotic drug discovery programs that focus on curing difficult-to-treat and hospital-acquired infections. These programs were based on Indel’s paradigm-changing antimicrobial drug discovery platform, a patented technology that opened a rich, new area of drug targets for the treatment of bacterial and parasitic infections and, potentially, fungal and viral infections.
If you are interested in this technology/platform please contact the University Industry Liaison Office at the University of British Columbia.
|
|
|
|
|
|
|
|
|
|
Indel Therapeutics
|
|
Health Care Equipment & Services
|
private:indeltherapeutics
|
493915
|
Feb 16th, 2018 12:00AM
|
Indel Therapeutics Inc.
|
96
|
0.00
|
Open
|
Biotechnology
|
Feb 16th, 2017 08:15AM
|
Feb 16th, 2017 08:15AM
|
Company has ceased operations.
Indel Therapeutics Inc. was a biopharmaceutical company dedicated to developing new drugs to address the global health crisis caused by antibiotic resistance. The Company had a growing pipeline of novel antibiotic drug discovery programs that focus on curing difficult-to-treat and hospital-acquired infections. These programs were based on Indel’s paradigm-changing antimicrobial drug discovery platform, a patented technology that opened a rich, new area of drug targets for the treatment of bacterial and parasitic infections and, potentially, fungal and viral infections.
If you are interested in this technology/platform please contact the University Industry Liaison Office at the University of British Columbia.
|
|
|
|
|
|
|
|
|
|
Indel Therapeutics
|
|
Health Care Equipment & Services
|
private:indeltherapeutics
|
493915
|
Feb 15th, 2018 12:00AM
|
Indel Therapeutics Inc.
|
96
|
0.00
|
Open
|
Biotechnology
|
Feb 15th, 2017 10:07AM
|
Feb 15th, 2017 10:07AM
|
Company has ceased operations.
Indel Therapeutics Inc. was a biopharmaceutical company dedicated to developing new drugs to address the global health crisis caused by antibiotic resistance. The Company had a growing pipeline of novel antibiotic drug discovery programs that focus on curing difficult-to-treat and hospital-acquired infections. These programs were based on Indel’s paradigm-changing antimicrobial drug discovery platform, a patented technology that opened a rich, new area of drug targets for the treatment of bacterial and parasitic infections and, potentially, fungal and viral infections.
If you are interested in this technology/platform please contact the University Industry Liaison Office at the University of British Columbia.
|
|
|
|
|
|
|
|
|
|
Indel Therapeutics
|
|
Health Care Equipment & Services
|
private:indeltherapeutics
|
493915
|
Feb 14th, 2018 12:00AM
|
Indel Therapeutics Inc.
|
96
|
0.00
|
Open
|
Biotechnology
|
Feb 14th, 2017 01:50PM
|
Feb 14th, 2017 01:50PM
|
Company has ceased operations.
Indel Therapeutics Inc. was a biopharmaceutical company dedicated to developing new drugs to address the global health crisis caused by antibiotic resistance. The Company had a growing pipeline of novel antibiotic drug discovery programs that focus on curing difficult-to-treat and hospital-acquired infections. These programs were based on Indel’s paradigm-changing antimicrobial drug discovery platform, a patented technology that opened a rich, new area of drug targets for the treatment of bacterial and parasitic infections and, potentially, fungal and viral infections.
If you are interested in this technology/platform please contact the University Industry Liaison Office at the University of British Columbia.
|
|
|
|
|
|
|
|
|
|
Indel Therapeutics
|
|
Health Care Equipment & Services
|
private:indeltherapeutics
|
493915
|
Feb 13th, 2018 12:00AM
|
Indel Therapeutics Inc.
|
96
|
0.00
|
Open
|
Biotechnology
|
Feb 13th, 2017 04:11PM
|
Feb 13th, 2017 04:11PM
|
Company has ceased operations.
Indel Therapeutics Inc. was a biopharmaceutical company dedicated to developing new drugs to address the global health crisis caused by antibiotic resistance. The Company had a growing pipeline of novel antibiotic drug discovery programs that focus on curing difficult-to-treat and hospital-acquired infections. These programs were based on Indel’s paradigm-changing antimicrobial drug discovery platform, a patented technology that opened a rich, new area of drug targets for the treatment of bacterial and parasitic infections and, potentially, fungal and viral infections.
If you are interested in this technology/platform please contact the University Industry Liaison Office at the University of British Columbia.
|
|
|
|
|
|
|
|
|
|
Indel Therapeutics
|
|
Health Care Equipment & Services
|
private:indeltherapeutics
|
493915
|
Feb 12th, 2018 12:00AM
|
Indel Therapeutics Inc.
|
96
|
0.00
|
Open
|
Biotechnology
|
Feb 12th, 2017 04:15AM
|
Feb 12th, 2017 04:15AM
|
Company has ceased operations.
Indel Therapeutics Inc. was a biopharmaceutical company dedicated to developing new drugs to address the global health crisis caused by antibiotic resistance. The Company had a growing pipeline of novel antibiotic drug discovery programs that focus on curing difficult-to-treat and hospital-acquired infections. These programs were based on Indel’s paradigm-changing antimicrobial drug discovery platform, a patented technology that opened a rich, new area of drug targets for the treatment of bacterial and parasitic infections and, potentially, fungal and viral infections.
If you are interested in this technology/platform please contact the University Industry Liaison Office at the University of British Columbia.
|
|
|
|
|
|
|
|
|
|
Indel Therapeutics
|
|
Health Care Equipment & Services
|
private:indeltherapeutics
|
493915
|
Feb 11th, 2018 12:00AM
|
Indel Therapeutics Inc.
|
96
|
0.00
|
Open
|
Biotechnology
|
Feb 11th, 2017 05:35AM
|
Feb 11th, 2017 05:35AM
|
Company has ceased operations.
Indel Therapeutics Inc. was a biopharmaceutical company dedicated to developing new drugs to address the global health crisis caused by antibiotic resistance. The Company had a growing pipeline of novel antibiotic drug discovery programs that focus on curing difficult-to-treat and hospital-acquired infections. These programs were based on Indel’s paradigm-changing antimicrobial drug discovery platform, a patented technology that opened a rich, new area of drug targets for the treatment of bacterial and parasitic infections and, potentially, fungal and viral infections.
If you are interested in this technology/platform please contact the University Industry Liaison Office at the University of British Columbia.
|
|
|
|
|
|
|
|
|
|
Indel Therapeutics
|
|
Health Care Equipment & Services
|
private:indeltherapeutics
|
493915
|
Feb 10th, 2018 12:00AM
|
Indel Therapeutics Inc.
|
96
|
0.00
|
Open
|
Biotechnology
|
Feb 10th, 2017 06:43AM
|
Feb 10th, 2017 06:43AM
|
Company has ceased operations.
Indel Therapeutics Inc. was a biopharmaceutical company dedicated to developing new drugs to address the global health crisis caused by antibiotic resistance. The Company had a growing pipeline of novel antibiotic drug discovery programs that focus on curing difficult-to-treat and hospital-acquired infections. These programs were based on Indel’s paradigm-changing antimicrobial drug discovery platform, a patented technology that opened a rich, new area of drug targets for the treatment of bacterial and parasitic infections and, potentially, fungal and viral infections.
If you are interested in this technology/platform please contact the University Industry Liaison Office at the University of British Columbia.
|
|
|
|
|
|
|
|
|
|
Indel Therapeutics
|
|
Health Care Equipment & Services
|
private:indeltherapeutics
|
493915
|
Feb 9th, 2018 12:00AM
|
Indel Therapeutics Inc.
|
96
|
0.00
|
Open
|
Biotechnology
|
Feb 9th, 2017 08:57AM
|
Feb 9th, 2017 08:57AM
|
Company has ceased operations.
Indel Therapeutics Inc. was a biopharmaceutical company dedicated to developing new drugs to address the global health crisis caused by antibiotic resistance. The Company had a growing pipeline of novel antibiotic drug discovery programs that focus on curing difficult-to-treat and hospital-acquired infections. These programs were based on Indel’s paradigm-changing antimicrobial drug discovery platform, a patented technology that opened a rich, new area of drug targets for the treatment of bacterial and parasitic infections and, potentially, fungal and viral infections.
If you are interested in this technology/platform please contact the University Industry Liaison Office at the University of British Columbia.
|
|
|
|
|
|
|
|
|
|
Indel Therapeutics
|
|
Health Care Equipment & Services
|